Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, provides funding and guidance for companies with an ambition to improve the patient journey and transform pharmaceutical R&D. Since 2017 Debiopharm has invested in more than 15 data-driven and digital health companies, typically leading the investment rounds.

Discover more on Debiopharm Innovation Fund at http://www.debiopharm.com/digital-health  and come meet with its team and other health innovators to dive deep into the ongoing challenges, strategic trends and scalable solutions likely to impact healthcare at FH23.